세계의 치료 기기 수탁제조 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 서비스별, 치료 영역별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Therapeutic Device Contract Manufacturing Market Summary

The global therapeutic device contract manufacturing market size was valued at USD 53.66 billion in 2024 and is projected to reach USD 159.76 billion by 2033, growing at a CAGR of 13.15% from 2025 to 2033. The market is driven by the increasing demand for advanced therapeutic devices, the rising trend of manufacturing outsourcing by medical device companies to reduce costs and accelerate time-to-market, and the growing prevalence of chronic diseases requiring innovative treatment solutions.

Global Therapeutic Device Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global therapeutic device contract manufacturing market report based on product, services, therapeutic area, end-use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Class I
• Class II
• Class III
• Services Outlook (Revenue, USD Million, 2021 - 2033)
• Accessories Manufacturing
• Assembly Manufacturing
• Component Manufacturing
• Device Manufacturing
• Packaging and Labeling
• Others
• Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular Devices
• Orthopedic Devices
• Ophthalmic Devices
• Respiratory Devices
• Surgical Instruments
• Dental
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Original Equipment Manufacturers (OEMs)
• Pharmaceutical & Biopharmaceutical Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Services
  • 1.2.3. Therapeutic Area
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Therapeutic Device Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Technological Advancements
• 3.4. Clinical trials volume analysis (2024)
• 3.5. Therapeutic Device Contract Manufacturing Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Analysis
  • 3.5.2. PESTEL Analysis

Chapter 4. Therapeutic Device Contract Manufacturing Market: Product Estimates & Trend Analysis

• 4.1. Therapeutic Device Contract Manufacturing Market, By Product: Segment Dashboard
• 4.2. Therapeutic Device Contract Manufacturing Market, By Product: Movement Analysis
• 4.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Product, 2021 - 2033
• 4.4. Class I
  • 4.4.1. Class I Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Class II
  • 4.5.1. Class II Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Class III
  • 4.6.1. Class III Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Therapeutic Device Contract Manufacturing Market: Services Estimates & Trend Analysis

• 5.1. Therapeutic Device Contract Manufacturing Market, By Services: Segment Dashboard
• 5.2. Therapeutic Device Contract Manufacturing Market, By Services: Movement Analysis
• 5.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Services, 2021 - 2033
• 5.4. Accessories Manufacturing
  • 5.4.1. Accessories Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Assembly Manufacturing
  • 5.5.1. Assembly Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Component Manufacturing
  • 5.6.1. Component Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Device Manufacturing
  • 5.7.1. Device Manufacturing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Packaging and Labeling
  • 5.8.1. Packaging and Labeling Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Therapeutic Device Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Therapeutic Device Contract Manufacturing Market, By Therapeutic Area: Segment Dashboard
• 6.2. Therapeutic Device Contract Manufacturing Market, By Therapeutic Area: Movement Analysis
• 6.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By Synthesis, 2021 - 2033
• 6.4. Cardiovascular Devices
  • 6.4.1. Cardiovascular Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Orthopedic Devices
  • 6.5.1. Orthopedic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ophthalmic Devices
  • 6.6.1. Ophthalmic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Respiratory Devices
  • 6.7.1. Respiratory Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Surgical Instruments
  • 6.8.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Dental
  • 6.9.1. Dental Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Therapeutic Device Contract Manufacturing Market: End Use Estimates & Trend Analysis

• 7.1. Therapeutic Device Contract Manufacturing Market, By End Use: Segment Dashboard
• 7.2. Therapeutic Device Contract Manufacturing Market, By End Use: Movement Analysis
• 7.3. Therapeutic Device Contract Manufacturing Market Estimates & Forecasts, By End Use, 2021 - 2033
• 7.4. Original Equipment Manufacturers (OEMs)
  • 7.4.1. Original Equipment Manufacturers (OEMs) Market, 2021 to 2033, (USD Million)
• 7.5. Pharmaceutical & Biopharmaceutical Companies
  • 7.5.1. Pharmaceutical & Biopharmaceutical Companies Market, 2021 to 2033, (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2021 to 2033, (USD Million)

Chapter 8. Therapeutic Device Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. U.S
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Thailand
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Australia
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.6. Oman
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Scenario
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.7. Qatar
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Competitive Scenario
    • 8.8.7.3. Regulatory Framework
    • 8.8.7.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Share Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Thermo Fisher Scientific Inc.
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Integer Holdings Corporation
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. FLEX LTD.
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Celestica Inc.
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Phillips-Medisize
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Plexus Corp
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Nipro Corporation
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Viant Technology LLC
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. West Pharmaceutical Services, Inc.
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Synecco Ltd
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives

Chapter 10. Key Recommendations